Riskpilot← Back to searchSign inGet full accessENFORME AS
ASActiveOrg 889417102Richard Johnsens Gate 4, 4021 StavangerOther human health activities n.e.c. · NACE 8699Est. 20062 employeeswww.enforme.no
Revenue 2025
NOK 2,2M
-18% vs 2024
EBITDA margin
44.0%
-38% vs 2024
Equity ratio
36.5%
Financial strength
Net profit 2025
NOK 776K
-59% vs 2024
| Revenue | NOK 2,2M | -18% |
| EBITDA | NOK 981K | -38% |
| Net profit | NOK 776K | -59% |
| Total assets | NOK 2,8M | -26% |
| Equity | NOK 1M | +8% |
| Employees | 2 | — |
Legal name
ENFORME AS
Org number
889417102
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
18. februar 2006
Share capital
NOK 163 532
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Helserelatert konsulentvirksomhet samt investeringer i andre helserelaterte selskaper.
Address
Richard Johnsens Gate 4, 4021 Stavanger
Website
www.enforme.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 2 593 | 4 138 | 4 021 | 5 051 | 5 671 | 4 214 | 3 530 | 2 680 | 1 024 | 1 236 | 1 434 | 1 285 | 1 107 | 1 132 | 1 510 | 2 965 | 2 736 | 2 230 |
| Staff expenses | −0 | −2 524 | −2 842 | −2 134 | −2 477 | −2 688 | −2 845 | −1 993 | −1 202 | −399 | −439 | −740 | −566 | −319 | −266 | −687 | −925 | −996 | −1 060 |
| EBITDA | 0 | −1 257 | −106 | −225 | 411 | 316 | −457 | −409 | 384 | 165 | 310 | 64 | 141 | 299 | 313 | 207 | 1 730 | 1 592 | 981 |
| Depreciation & amort. | −0 | −60 | −285 | −269 | −326 | −312 | −345 | −156 | −88 | −116 | −145 | −103 | −55 | −133 | −151 | −156 | −129 | −53 | −48 |
| EBIT | 0 | −1 318 | −391 | −494 | 85 | 4 | −803 | −565 | 296 | 49 | 166 | −39 | 86 | 166 | 162 | 51 | 1 601 | 1 539 | 933 |
| Net financials | 0 | 7 | −0 | −14 | −37 | −22 | −39 | −46 | −48 | −45 | −24 | −15 | −13 | −17 | −7 | −5 | 3 | 2 | 0 |
| Profit before tax | 0 | −1 311 | −391 | −508 | 48 | −18 | −842 | −611 | 248 | 4 | 142 | −54 | 73 | 149 | 155 | 46 | 1 605 | 1 542 | 933 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −369 | 157 |
| Net profit | 0 | −1 311 | −391 | −508 | 48 | −18 | −842 | −611 | 248 | 4 | 142 | −54 | 73 | 149 | 155 | 46 | 1 605 | 1 911 | 776 |
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | 655 | 2 092 | 1 681 | 1 676 | 2 022 | 1 035 | 901 | 648 | 729 | 720 | 532 | 664 | 1 130 | 1 302 | 810 | 2 452 | 3 798 | 2 827 |
| Equity | — | −578 | 1 237 | 729 | 777 | 759 | 378 | −233 | 15 | 19 | 161 | 107 | 180 | 329 | 354 | 340 | 645 | 956 | 1 032 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 396 | 450 | 300 | 130 | 130 | 357 | 149 | 38 | 0 | 701 | 0 |
| Short-term debt | 0 | 1 233 | 855 | 951 | 899 | 1 262 | 657 | 1 134 | 237 | 260 | 259 | 295 | 354 | 444 | 798 | 432 | 1 807 | 2 142 | 1 094 |
| Total debt | 0 | 1 233 | 855 | 951 | 899 | 1 262 | 657 | 1 134 | 633 | 710 | 559 | 425 | 484 | 801 | 948 | 470 | 1 807 | 2 842 | 1 795 |
EBITDA margin
44.0%
This company
15.8%
Market median
+178% vs market
20072025
Equity ratio
36.5%
This company
38.2%
Market median
+4% vs market
20072025
Return on equity
75.2%
This company
18.4%
Market median
+309% vs market
20072025
Net profit margin
34.8%
This company
8.1%
Market median
+330% vs market
20072025
Asset turnover
0.79×
This company
1.12×
Market median
-29% vs market
20072025
Debt / equity
1.74×
This company
0.62×
Market median
-181% vs market
20072025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via Brønnøysundsregistrene · Period 2007-01-01 – 2007-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RC Deputy Member | Deputy Member | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Sivi Investering As | Company | 97.8% | 97.8% | 2022 |
| Individual | 2.2% | 2.2% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Sivi Investering As
ENFORME AS Board members of ENFORME AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rune Christian Taarland | Deputy Member | 0 companies |
| Sigurd Vik | Chairman | 0 companies |